Global Cell Harvesting System Market By Application, By End Use, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: Jul 2022
- Report ID: 52508
- Number of Pages: 265
- Format:
- account_circleAbout Me
Report Overview
The Cell Harvesting System Market is expected to be worth around USD 22,933.57 million by 2031 from USD 6,076.8 million in 2021, growing at a CAGR of 14.2% during the forecast period from 2021 to 2031.
The Cell Harvesting System Market growth is driven by rising demand for stem cell-based treatment and increased investment in scientific research due to its possible benefits in recovering medicines.
Global Cell Harvesting System Market Scope:
Application analysis
This technique can be used for stem cells extracted from the bone marrow, peripheral blood, and umbilical cord. Peripheral blood dominated the market in 2016. It is expected to preserve its dominant position over the forecast period time. This is due in part to the growing use of marginal Plasma in stem-cell replacement and in part to the increased use in stem-cell research.
Adipose tissue will see the greatest growth due to liposuction’s ability to extract more stem cells and potentially use these harvesting processes in regenerative medicines. The potential for its use in other therapies and increasing transplantation use will be major factors in the umbilical cord’s lucrative growth factor.
End-Use analysis
According to end-use, there is four segment scope of the market: academic institutes, clinics, and hospitals. Hospitals hold the largest market share and will continue to dominate over the coming years. This is because most stem cell transplants and research take place in hospitals.
Higher investment by universities and biopharmaceutical industry corporations in research will lead to the greatest growth of academic institutes, R&D centers, and R&D centers. The rising demand for skin cell-based treatments and regenerative medicine will drive research in academic institutions to continue to expand.
Кеу Маrkеt Ѕеgmеntѕ
By Application
- Umbilical Cord
- Bone Marrow
- Peripheral Blood
- Adipose tissue
- Other sources
By End-Use
- Hospitals
- Clinics
- Academic institutes
- R&D centers
Cell Harvesting System Market Dynamics:
Stem cell-based therapy will continue to grow in demand for stem cell systems due to an aging population and the rising prevalence of chronic diseases such as heart disease. Stem cell-based research has seen a dramatic increase in the last decade. This is a major driving factor in the demand for cell harvesting for research. The National Institutes of Health (NIH), the primary U.S. agency for biomedical research and public health, spent USD 1.49 billion on research in 2016. This was approximately 5.0% more than in 2015.
Stem cell banking is also rising due to the increasing transplantation rate. Research into stem cell sources such as embryonic stem cells and umbilical cord stem cells drives the development of regenerative products and cancer treatment.
The market’s growth will be limited by ethical concerns regarding embryonic stem cells and unapproved stem cell therapy offered by healthcare providers in unregulated areas such as Latin America and Asia Pacific.
Regional Analysis
North America and Europe comprised 74% of the total revenue, while Europe dominated in 2021. It is also home to the majority of stem cell transplants. Europe holds a larger Cell Harvesting System Market share of the Cell Harvesting System Market.
North American market was the leading research region regional scoop in 2021, with over 54.5% of stem cell clinical trials performed in this area. The second main stem cell replacement is also found in this province. This increases the need for garnering.
Asia Pacific is expected to see significant growth rates of long-lasting disease modeling and increased demand for stem cell replacement. Asia Pacific’s top stem cell harvesting system market share includes China and Japan. The forecast period will see developing nations such as South Korea, South Africa, and Mexico experience significant growth. These countries have a rising demand for stem cell therapies. This is due to the higher investment of governments in stem cell-based research.
Key Regions and Countries covered іn thе rероrt:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East
- GCC
- South Africa
- Israel
- Rest of the Middle East
Market Share & Key Players Analysis:
Terumo Corporation offers a variety of products, including harvesters and apheresis systems. Terumo BCT established a strategic partnership with Cognate Bioservices, a service contract company Share, in September 2016 to develop immunotherapy products and increase the use of quantum systems in cell therapy manufacturing.
Маrkеt Кеу Рlауеrѕ:
- Argos Technologies, Inc.
- Perkin Elmer Inc
- Brand GmBh + CO KG
- Aralon Color GmbH
- Arthrex Inc.
- Microchip Technology Inc.
- Linear technology
- Avita Medical.
- Tomtec
- Bionic Power Inc.
- Convergence Inc.
- Terumo BCT Inc.
- Teleflex Inc.
- Bertin
- Other Key players
For the Cell Harvesting System Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Market Size in 2022
USD 6,076.8 million
Growth Rate
14.2%
Forecast Value in 2032
USD 22,933.57 million
Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Frequently Asked Questions (FAQ)
What is the size of the Cell Harvesting System market in 2021?
The Cell Harvesting Systems market size is US$ 6,076.84 million in 2021.
What is the projected CAGR at which the Cell Harvesting System market is expected to grow at?
The Cell Harvesting System market is expected to grow at a CAGR of 14.2% (2023-2032).
List the segments encompassed in this report on the Cell Harvesting System market?
Market.US has segmented the Cell Harvesting System market by geography (Latin America, Europe, APAC, South America, and Middle East and Africa). By Application, the market has been segmented into Umbilical Cord, Bone marrow, Peripheral Blood, and Adipose Tissue. By End Use, the market has been further divided into Hospitals, Clinics, and R&D Centers.
List the industry key market player in the Cell Harvesting System market?
Argos Technologies, Inc.; Perkin Elmer, Inc.; Brand GmBh + CO KG; Arthrex, Inc.; Avita Medical; Tomtec; Terumo Corporation; Teleflex, Inc.; Bertin., and Other major Players in Cell Harvesting System market.
Cell Harvesting System Market
Published date: Jul 2022 • Formats:add_shopping_cartBuy Now get_appDownload Sample - account_circleAbout Me
- ondemand_videoVideos
- Argos Technologies, Inc.
- Perkin Elmer Inc
- Brand GmBh + CO KG
- Aralon Color GmbH
- Arthrex Inc.
- Microchip Technology Inc. Company Profile
- Linear technology
- Avita Medical.
- Tomtec
- Bionic Power Inc.
- Convergence Inc.
- Terumo BCT Inc.
- Teleflex Inc.
- Bertin
- Other Key players
- settingsSettings
Single User
$5,999
$4,499
USD / per unit
save 25%
|
Multi User
$7,999
$4,999
USD / per unit
save 38%
|
Corporate User
$9,999
$5,499
USD / per unit
save 45%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |